Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
PennyMac Financial Services, Inc. (NYSE:PFSI) CEO Sells $1,049,500.00 in Stock
PennyMac Financial Services, Inc. (NYSE:PFSI – Get Free Report) CEO David Spector sold 10,000 shares of the firm’s stock in...
Insider Selling: Construction Partners, Inc. (NASDAQ:ROAD) Director Sells 46,596 Shares of Stock
Construction Partners, Inc. (NASDAQ:ROAD – Get Free Report) Director Charles E. Owens sold 46,596 shares of the business’s stock in...
ACI Worldwide, Inc. (NASDAQ:ACIW) CTO Abraham Kuruvilla Sells 5,400 Shares
ACI Worldwide, Inc. (NASDAQ:ACIW – Get Free Report) CTO Abraham Kuruvilla sold 5,400 shares of the stock in a transaction...
Insider Selling: Radian Group Inc. (NYSE:RDN) Insider Sells 14,705 Shares of Stock
Radian Group Inc. (NYSE:RDN – Get Free Report) insider Derek Brummer sold 14,705 shares of the company’s stock in a...
Post Holdings, Inc. (NYSE:POST) SVP Bradly A. Harper Sells 1,000 Shares
Post Holdings, Inc. (NYSE:POST – Get Free Report) SVP Bradly A. Harper sold 1,000 shares of the company’s stock in...
First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC) Stock Price Passes Above 200-Day Moving Average – Time to Sell?
First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC – Get Free Report) shares crossed above its 200-day moving average during...